title: Percutaneous radiofrequency ablation of small renal cell carcinoma: technique, complications, and outcomes.
abstract: Imaging-guided radiofrequency ablation (RFA) is an option for treatment in patients with early-stage small renal cell carcinomas (RCCs). RFA has been introduced to treat focal renal tumors, particularly incidental lesions <3 cm in elderly patients and those with comorbid conditions. Other  uses have included treatment in patients with von Hippel-Lindau syndrome and other diseases that predispose patients to multiple renal carcinomas, where renal parenchymal preservation is desired. It appears that this technique has a low complication rate, preserves renal function, is well tolerated by the patients, and, in a high percentage of patients, can eradicate small renal tumors. Techniques, patient selection, complications, and results are discussed.
authors: Institute of Radiology, University Medical Centre Ljubljana, Ljubljana, Slovenia. peter.popovic@kclj.si
authors: P
authors: P
authors: Popovic
authors: S
authors: S
authors: Lukic
authors: M
authors: M
authors: Mijailovic
authors: V
authors: V
authors: Salapura
authors: M
authors: M
authors: Garbajs
authors: K
authors: K
authors: Surlan Popovic
mesh_terms: D002292:Carcinoma, Renal Cell / Q000601:surgery*; D017115:Catheter Ablation / Q000009:adverse effects / Q000379:methods*; D006801:Humans; D007680:Kidney Neoplasms / Q000601:surgery*; D018579:Patient Selection; D016896:Treatment Outcome